SEPN
Septerna, Inc.
NASDAQ · Healthcare · Biotechnology · US
$36.75
−0.14%Margins
Gross margin
99.6%
EBITDA margin
-40.2%
EBIT margin
-44.0%
Net margin
-24.5%
FCF margin
106.3%
-6.3%
Return on equity
-4.3%
Return on assets
-10.6%
Return on invested capital
0.17x
Asset turnover
$106.0M
Cash from operations
$7.98
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026